Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2008, p. 1104-1105, Vol. 46, No. 3
0095-1137/08/$08.00+0 doi:10.1128/JCM.02259-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Pathology, Johns Hopkins Medical Institutions, 600 North Wolfe Street, Baltimore, Maryland 21287,1 Makerere University-Johns Hopkins University Research Collaboration Laboratory, Old Mulago Hill Road, Kampala, Uganda2
Received 21 November 2007/ Returned for modification 19 December 2007/ Accepted 4 January 2008
|
|
|---|
|
|
|---|
The Roche Amplicor HIV-1 DNA test version 1.0 required a 100-µl blood volume from infants less than 18 months of age and 500 µl from infants greater than 18 months of age. However, according to the manufacturer's new version 1.5 package insert, 500 µl of blood is required regardless of age. As it is often difficult to obtain 500 µl of blood or more from infants who may require multiple tests on a small volume of blood, the objective of this study was to validate the use of 100 µl of blood for infants under 18 months of age in the version 1.5 assay by comparing the concordance rates of positivity and negativity for the two different blood volumes.
In this study, blood samples were obtained from 38 babies previously determined by PCR (using 500 µl of whole blood) to be positive for HIV type 1 (HIV-1) DNA and 16 HIV-1 DNA PCR-negative babies aged 6 weeks to 18 months who visited the clinics at Mulago Hospital, Kampala, Uganda, and whose mothers or guardians gave consent for HIV DNA testing. Approximately 1 ml of blood from each baby was collected in EDTA anticoagulant and transported to the Makerere University-Johns Hopkins University Uganda Core Laboratory. The processing technician at the core laboratory made one or more cell pellets from 100- and 500-µl aliquots of each blood sample (Table 1). Three milliliters of specimen wash buffer was used to prepare and wash each cell pellet from 100 or 500 µl of whole blood. The Amplicor HIV-1 DNA PCR test version 1.5 was run on the two pellets from each specimen according to the manufacturer's instructions. Kit controls and coded control pellets were used for the validation of each assay run. The technologist running the assay was blinded as to the HIV status of each infant.
|
View this table: [in a new window] |
TABLE 1. HIV-1 DNA PCR results for testing of 100- and 500-µl samples of whole blood from infants 6 weeks to 18 months of age born to HIV-infected mothers
|
Our comparison revealed no significant difference in the HIV-1 DNA PCR test results obtained using 100- and 500-µl blood volumes in the cell pellet preparation for the Roche Amplicor HIV-1 DNA PCR test version 1.5. A limitation of our study is that blood samples from infants less than 6 weeks of age, when HIV DNA levels may be lower, although lymphocyte counts are typically higher in very young infants, were not available for testing. Nevertheless, because of the difficulties encountered during venipuncture in infants less than 18 months old and the need to minimize the risk of anemia, our data indicate that a volume of 100 µl of blood can be used in the cell pellet preparation for the Amplicor HIV-1 DNA PCR test version 1.5, at least for infants greater than 8 weeks of age.
Published ahead of print on 16 January 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»